Bacliff, TX, United States of America

Christopher Kuyler Doyle

USPTO Granted Patents = 8 


Average Co-Inventor Count = 2.1

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Brussels, BE (2017)
  • San Rafael, CA (US) (2017)
  • Bacliff, TX (US) (2010 - 2022)

Company Filing History:


Years Active: 2010-2022

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Christopher Kuyler Doyle: Innovator in Immunoreactive Compositions

Introduction

Christopher Kuyler Doyle is a notable inventor based in Bacliff, Texas, with a significant contribution to the field of immunoreactive compositions. He holds a total of eight patents, showcasing his innovative approach to scientific research and development.

Latest Patents

Among his latest patents, Doyle has developed immunoreactive protein orthologs, specifically focusing on gp36 and gp47 immunoreactive compositions. These inventions detail the use of tandem repeats with carbohydrate moieties, which are crucial for the efficacy of the compositions. Additionally, he has worked on gp19 immunoreactive compositions, which include vaccines, antibodies, polypeptides, peptides, and polynucleotides, further expanding the scope of his research.

Career Highlights

Doyle is affiliated with the Research Development Foundation, where he applies his expertise in immunology and protein research. His work has led to advancements in the understanding and application of immunoreactive proteins, contributing to the development of new therapeutic options.

Collaborations

Throughout his career, Doyle has collaborated with esteemed colleagues such as Jere W McBride and David H Walker, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Christopher Kuyler Doyle's contributions to the field of immunoreactive compositions highlight his innovative spirit and dedication to scientific advancement. His patents reflect a commitment to improving health outcomes through research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…